1. Argentina Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Laboratorios Richmond S.A.C.I.F.

Laboratorios Richmond S.A.C.I.F.

RICH.BA
Laboratorios Richmond S.A.C.I.F.AR flagBuenos Aires Stock Exchange
1,540.00
ARS
-45.00
- -
124.36BMarket Cap

Total Valuation

Laboratorios Richmond S.A.C.I.F. carries a market capitalization of 124.36B, placing it among publicly traded companies globally. Its enterprise value stands at 368.27B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap124.36B
Enterprise Value368.27B

Share Statistics

Laboratorios Richmond S.A.C.I.F. currently has 80.75M shares outstanding.

Shares Outstanding80.75M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Laboratorios Richmond S.A.C.I.F. trades at a trailing price-to-earnings ratio of 7.43. The price-to-sales ratio is 1.08, and the price-to-book ratio stands at 5.40.

PE Ratio7.43
PS Ratio1.08
PB Ratio5.40
P/TBV Ratio1.95
P/FCF Ratio4.83
P/OCF Ratio-67.44

Enterprise Valuation

On an enterprise value basis, Laboratorios Richmond S.A.C.I.F. trades at an EV/EBITDA multiple of 13.49 and an EV/FCF ratio of 9.39. The EV/Sales ratio of 2.98 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 13.49 provides insight into valuation relative to core operating earnings.

EV / Sales2.98
EV / EBITDA13.49
EV / EBIT13.49
EV / FCF9.39

Financial Position

Laboratorios Richmond S.A.C.I.F. maintains a current ratio of 0.98, meaning it holds 1.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 192.89, indicating elevated leverage, while an interest coverage ratio of 1.70 demonstrates limited ability to service its debt obligations.

Current Ratio0.98
Quick Ratio0.03
Debt / Equity192.89
Debt / EBITDA8.64
Interest Coverage1.70

Financial Efficiency

Laboratorios Richmond S.A.C.I.F. posts a return on equity of 75.98 and a return on invested capital of 7.92.

Return on Equity (ROE)75.98
Return on Assets (ROA)4.93
Return on Invested Capital (ROIC)7.92
Return on Capital Employed (ROCE)17.30
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover1.30

Taxes

Over the trailing twelve months, Laboratorios Richmond S.A.C.I.F. has paid 6.86B in income taxes, reflecting an effective tax rate of 28.49.

Income Tax6.86B
Effective Tax Rate28.49

Stock Price Statistics

Laboratorios Richmond S.A.C.I.F.'s stock has gained approximately 13.23529% over the past 52 weeks. The 50-day moving average sits at 1,592.70, while the 200-day moving average is 1,681.78.

Beta (5Y)N/A
52-Week Price Change13.23529%
50-Day Moving Average1,592.70
200-Day Moving Average1,681.78
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Laboratorios Richmond S.A.C.I.F. generated 123.62B in revenue and converted that into 18.05B in net income, yielding earnings per share of 213.09. EBITDA reached 27.30B, while operating income came in at 27.30B.

Revenue123.62B
Gross Profit76.82B
Operating Income27.30B
Pretax Income24.06B
Net Income18.05B
EBITDA27.30B
EBIT27.30B
Earnings Per Share (EPS)213.09

Balance Sheet

Laboratorios Richmond S.A.C.I.F. holds 3.24B in cash and equivalents against 235.79B in total debt, resulting in a net debt position of 213.91B. Total book value stands at 24.82B, with working capital of -2.44B providing operational flexibility.

Cash & Cash Equivalents3.24B
Total Debt235.79B
Net Debt213.91B
Equity (Book Value)24.82B
Book Value Per Share307.33
Working Capital-2.44B

Cash Flow

Laboratorios Richmond S.A.C.I.F. produced -1.99B in operating cash flow over the past twelve months. After subtracting -29.74B in capital expenditures, free cash flow totaled -31.72B - equivalent to -392.86 per share.

Operating Cash Flow-1.99B
Capital Expenditures-29.74B
Free Cash Flow-31.72B
FCF Per Share-392.86

Margins

Laboratorios Richmond S.A.C.I.F. operates with a gross margin of 62.14, reflecting its pricing power and cost economics. The operating margin of 22.08 and net profit margin of 14.60 provide insight into operational efficiency.

Gross Margin62.14
Operating Margin22.08
Pretax Margin19.47
Profit Margin14.60
EBITDA Margin22.08

Dividends & Yields

The company's payout ratio of 1.93 indicates the proportion of earnings distributed to shareholders.

Dividend Per Share4.07
Dividend YieldN/A
Payout Ratio1.93
Shareholder Yield-20.05
FCF Yield20.70

Scores

Laboratorios Richmond S.A.C.I.F. posts an Altman Z-Score of 0.90, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score0.90